Short-term anti-vascular endothelial growth factor treatment elicits vasculogenic mimicry formation of tumors to accelerate metastasis.
about
Tumor cell vasculogenic mimicry: from controversy to therapeutic promiseEscaping Antiangiogenic Therapy: Strategies Employed by Cancer CellsRevisiting tumor angiogenesis: vessel co-option, vessel remodeling, and cancer cell-derived vasculature formationAssociation between NQO1 C609T polymorphism and prostate cancer riskHMGA2 promotes vasculogenic mimicry and tumor aggressiveness by upregulating Twist1 in gastric carcinomaHIF-1α induces VE-cadherin expression and modulates vasculogenic mimicry in esophageal carcinoma cells.Lack of association between MTHFD1 G401A polymorphism and ovarian cancer susceptibility.Metastasis-associated in colon cancer-1 promotes vasculogenic mimicry in gastric cancer by upregulating TWIST1/2.Wnt3a Promotes the Vasculogenic Mimicry Formation of Colon Cancer via Wnt/β-Catenin SignalingTivantinib induces G2/M arrest and apoptosis by disrupting tubulin polymerization in hepatocellular carcinoma.Vasculogenic Mimicry in Prostate Cancer: The Roles of EphA2 and PI3K.cRGD inhibits vasculogenic mimicry formation by down-regulating uPA expression and reducing EMT in ovarian cancer.Hypoxia-induced vasculogenic mimicry formation in human colorectal cancer cells: Involvement of HIF-1a, Claudin-4, and E-cadherin and Vimentin.The Pleiotropic Role of L1CAM in Tumor VasculatureM2-like tumor-associated macrophages drive vasculogenic mimicry through amplification of IL-6 expression in glioma cells.Tumor cell vascular mimicry: Novel targeting opportunity in melanoma.Combretastatin A4 phosphate treatment induces vasculogenic mimicry formation of W256 breast carcinoma tumor in vitro and in vivo.A transfection method of PS-asODNs targeting ANGPTL4 in multicellular structures of hepatocarcinoma cell line.N-cadherin participated in invasion and metastasis of human esophageal squamous cell carcinoma via taking part in the formation of vasculogenic mimicry.Therapeutic targeting of tetraspanin8 in epithelial ovarian cancer invasion and metastasis.Regulatory Role of the MicroRNA-29b-IL-6 Signaling in the Formation of Vascular Mimicry.VEGFR2 regulates endothelial differentiation of colon cancer cells.Autophagy-induced KDR/VEGFR-2 activation promotes the formation of vasculogenic mimicry by glioma stem cells.Acquired tumor resistance to antiangiogenic therapy: Mechanisms at a glance.ZEB1-repressed microRNAs inhibit autocrine signaling that promotes vascular mimicry of breast cancer cells.Long Non-coding RNA LINC00339 Stimulates Glioma Vasculogenic Mimicry Formation by Regulating the miR-539-5p/TWIST1/MMPs Axis.Vasculogenic mimicry in bladder cancer and its association with the aberrant expression of ZEB1.Association between estrogen receptor alpha PvuII polymorphism and prostate cancer risk.NHERF1 and tumor microenvironment: a new scene in invasive breast carcinoma.Prognostic significance of galectin-1 and vasculogenic mimicry in patients with gastric cancer.Cellular communication promotes mammosphere growth and collective invasion through microtubule‑like structures and angiogenesisOverview of advances in vasculogenic mimicry - a potential target for tumor therapy
P2860
Q26829921-8ACED09F-9DE4-44A5-A5AA-5FC72A6F606DQ28067753-4E937FC1-BA99-4623-9DDF-0766E1DB0F36Q28077123-F19056E8-5FCB-4BC0-83D0-41D48D1BCFD0Q28240340-FFCCADE0-F642-4F32-B553-5E65F9104B67Q33714914-E8392A15-D5B7-4CD7-B710-D8826D5D8DF7Q34750633-C0DFA7D4-F0A8-4330-894A-93895C2A5FFDQ35056269-04FC9007-9D15-4372-995A-C1E1DA1BD805Q35793839-73F59E52-C3AC-4F23-91C8-BB9061896EE5Q36088595-F2F554A7-FCB5-4BD3-B281-0AF1031CDE5AQ36156854-0748FBC4-E80F-42FE-9748-ABEFCADA6E48Q37015731-D7FBC87F-F2B7-45F3-926D-6DA12D757571Q37269211-C2CE7444-02C8-4A39-9D25-C2238D66C148Q37424797-D61C12C5-902F-44BC-A4D4-46742457BED8Q37690651-E1E7797F-505E-487D-9B56-D4B922A1ED98Q37702362-681C6B3C-5260-4A50-B7FC-0237458833F0Q38710798-8682C31C-979E-4B7E-AC3A-AABE0628A125Q38869295-CB4A293C-DF7B-439C-8602-D783D9A7AEE8Q38882897-BDC49C54-E006-4249-BEC2-F498EE6373B6Q38921577-FFE5396F-229D-4950-BE83-B9F6D2320137Q40068293-AEA18478-4757-49D1-8193-5F973DB0D7EAQ40984509-778096C0-371A-461B-9B2B-FB01DD87D4DFQ41570454-AFFC1787-1A12-4E3B-9D8A-891004385376Q41912135-E83CC347-47EE-4C57-9FBE-E1BCEB261532Q47098476-3BA32CED-FEF0-41AA-BCD8-B95E71022574Q47588078-5D3C1839-098C-49EE-B141-7FCBF69A0F24Q49522374-15EB91AD-5164-4702-846E-5FD022C93156Q52649722-0308450E-CA75-49FA-B61D-6DC3A6A1D57EQ53134069-07212CD1-23DB-43A7-A1E4-67C89424B3EDQ54967336-FA3F8AC7-0019-4E91-9587-D39681C8D7DBQ55329371-4219CC30-450A-4343-8F72-1E7B22DC0534Q58777021-F1872D68-9D97-4D83-9050-1181FC783681Q58803491-09F3C069-3157-4155-9AD6-444A1E87F29A
P2860
Short-term anti-vascular endothelial growth factor treatment elicits vasculogenic mimicry formation of tumors to accelerate metastasis.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Short-term anti-vascular endot ...... mors to accelerate metastasis.
@ast
Short-term anti-vascular endot ...... mors to accelerate metastasis.
@en
type
label
Short-term anti-vascular endot ...... mors to accelerate metastasis.
@ast
Short-term anti-vascular endot ...... mors to accelerate metastasis.
@en
prefLabel
Short-term anti-vascular endot ...... mors to accelerate metastasis.
@ast
Short-term anti-vascular endot ...... mors to accelerate metastasis.
@en
P2093
P2860
P356
P1476
Short-term anti-vascular endot ...... mors to accelerate metastasis.
@en
P2093
P2860
P2888
P356
10.1186/1756-9966-31-16
P577
2012-02-23T00:00:00Z
P5875
P6179
1028782704